Clear Search sequence regions


  • diagnosis (2)
  • drug therapies (1)
  • empowers (1)
  • endonucleases (2)
  • fusion genes (3)
  • g quadruplex (2)
  • human (2)
  • isoforms (5)
  • leukemia (4)
  • nucleic acid (2)
  • oncoprotein (1)
  • PML (5)
  • prognosis (1)
  • RARA (5)
  • receptor (1)
  • serum (1)
  • Sizes of these terms reflect their relevance to your search.

    Accurate detection and classification of the three isoforms of PML/RARA genomic fragments are crucial for predicting disease progression, stratifying risk, and administering precise drug therapies in acute promyelocytic leukemia (APL). In this study, we have developed a highly specific nucleic acid detection platform capable of quantifying the long isoform of the three main PML-RARA isoforms at a constant temperature. This platform integrates the strengths of the CRISPR/Cas12a nuclease-based method and the rolling circle amplification (RCA) technique. Notably, the RCA-assisted CRISPR/Cas12a trans-cleavage system incorporates a spatial confinement effect by utilizing intermolecular G-quadruplex structures. This innovative design effectively enhances the local concentration of CRISPR/Cas12a, thereby accelerating its cleaving efficiency towards reporter nucleic acids and enabling the detection of PML/RARA fusion gene expression through spectroscopy. The robust detection of PML/RARA fusion gene from human serum samples validates the reliability and potential of this platform in the screening, diagnosis, and prognosis of APL cases. Our findings present an approach that holds significant potential for the further development of the robust CRISPR/Cas sensor system, offering a rapid and adaptable paradigm for APL diagnosis. Copyright © 2023. Published by Elsevier B.V.

    Citation

    Xinrui Wang, Dan Zheng, Chengyi Wang, Danni Xue, Qi Wang, Juan Xia. Harnessing intermolecular G-quadruplex-based spatial confinement effect for accelerated activation of CRISPR/Cas12a empowers ultra-sensitive detection of PML/RARA fusion genes. Analytica chimica acta. 2024 Jan 25;1287:342108

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38182385

    View Full Text